Durham, NC, United States of America

David Alcorta

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by David Alcorta in Cancer Therapy

Introduction

David Alcorta is an accomplished inventor based in Durham, NC, known for his significant contributions to cancer treatment technologies. With a total of four patents to his name, Alcorta has focused on developing innovative methods and systems that enhance the efficacy of cancer therapies.

Latest Patents

Among his latest patents is the X-ray psoralen activated cancer therapy (X-PACT), which presents a method for treating diseased sites in human or animal bodies. This method involves injecting phosphors capable of emitting ultraviolet or visible light into the affected area. Additionally, he has developed a system for the same therapy, which includes a pharmaceutical carrier with phosphors, a photoactivatable drug for DNA intercalation, devices for drug infusion, an x-ray or high-energy electron source, and a processor to control the dosage of x-rays or electrons. This innovative approach aims to activate the photoactivatable drug within tumors, enhancing treatment effectiveness.

Career Highlights

David Alcorta has worked with notable organizations such as Immunolight, LLC and Duke University. His work in these institutions has allowed him to advance his research and contribute to the field of cancer therapy significantly.

Collaborations

Alcorta has collaborated with esteemed colleagues, including Frederic Avery Bourke, Jr. and Neil Lee Spector, further enriching his research and development efforts in cancer treatment technologies.

Conclusion

David Alcorta's innovative work in cancer therapy, particularly through his X-PACT patents, showcases his commitment to improving treatment methods. His contributions are paving the way for more effective cancer therapies, ultimately benefiting patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…